Sarepta’s Duchenne Gene Therapy Placed on Hold in Europe Pending Death Investigation

The European Medicines Agency asked for three clinical trials to be placed on hold until the exact cause of death of a US teenager, who suffered acute liver failure after receiving Elevidys, can be precisely determined.

Scroll to Top